SAFE-PLASMA Protocol

HT9427-27-SSN-701

DEPT OF DEFENSE › DEFENSE HEALTH AGENCY (DHA) › DEFENSE HEALTH AGENCY

MD, 21702

Responses due

Nov 16, 2026, 2:00 PM EST

6 days left

SAM.gov

Notice type: Sources Sought
Set-aside: None
NAICS: 541715; Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC: —
Posted: Nov 10, 2026
Last updated: Nov 10, 2026
Office: DEFENSE HEALTH AGENCY
Versions: 1

Description

The Defense Health Agency Contracting Activity, on behalf of Portfolio Acquisition Executive for Medical Products, Warfighter Protection and Acute Care Project Management Office, intends to issue a contract modification on a sole-source basis with Westat Inc. 1600 Research Blvd. Rockville, MD 20850. This modification will enable Westat Inc. to modify the current clinical trial design to comply with FDA recommendations and to conduct the Good Clinical Practices (GCP) compliant clinical trial in accordance with U.S. Food and Drug Administration’s requirements for EZPLAZ™ approval.

Points of contact

Primary contact

Jamie Diggs

jamie.l.diggs.civ@health.mil

Contracting office

DEPT OF DEFENSE

DEFENSE HEALTH AGENCY (DHA)

DEFENSE HEALTH AGENCY

MEDICAL R & D CONTRACTING DIVISION 2

808 SCHREIDER STREET

FORT DETRICK, MD, 21702

Classification

NAICS

541715

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

54├Professional, Scientific, and Technical Services

541├Professional, Scientific, and Technical Services

5417├Scientific Research and Development Services

54171├Research and Development in the Physical, Engineering, and Life Sciences

541715└Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)